Erica Monaco- CEO

Erica Monaco serves as Chief Executive Officer for Biofrontera Inc. She joined Biofrontera in 2016 and has accepted progressive positions culminating in her appointment to the Board of Directors of Biofrontera Inc. as Chief Financial Officer in January 2020. Erica has provided leadership and has been a key contributor in the success of Biofrontera Inc., from the earliest stages including the launch of the flagship products to the development of the business structure, processes and partnerships required to operate and grow the subsidiary into a $25M entity in 3 years. She was integral to the 2019 merger and integration of Cutanea Life Sciences.